secwatch.observer — SEC 8-K summary
======================================

Issuer:     BICYCLE THERAPEUTICS PLC (BCYC)
CIK:        0001761612
Form:       8-K
Filed at:   2025-03-27T23:59:59+00:00
Accession:  0001104659-25-028531
Event type: leadership
Sentiment:  positive
Materiality: 0.70
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bicycle Therapeutics appoints Alessandro Riva to board, names Felix Baker chairman, promotes Eric Westin to CMO
--------------------------------------------------------------------------------

- Pierre Legault and Richard Kender to retire from board after AGM June 17, 2025; Felix Baker to become chairman.
- Alessandro Riva joins board and scientific committee; receives annual cash $60k, option 25k shares, RSU 12.5k shares vesting over 3 years.
- CDO Santiago Arroyo resigned March 24; separation includes pro-rated 2025 bonus, COBRA to May 2025; consulting fee $12k/yr, equity continues vesting.
- Eric Westin promoted to CMO; Jim MacDonald-Clink promoted to SVP head of business development.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1761612/000110465925028531/0001104659-25-028531-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1761612/000110465925028531/tm2510464d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-028531

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer